Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


02.04.2018

1 Ann Neurol
1 Curr Treat Options Neurol
1 Diabet Med
1 J Autoimmun
1 J Immunol
1 J Neuroimmunol
1 J Neurol
1 J Pediatr
3 Kidney Int
2 Lancet
2 Lancet Diabetes Endocrinol
4 Mult Scler
1 Nat Rev Neurol
2 Neurology
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. CRAMER SP, Simonsen HJ, Varatharaj A, Galea I, et al
    Permeability of the blood-brain barrier predicts no evidence of disease activity at two years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.
    Ann Neurol. 2018 Mar 31. doi: 10.1002/ana.25219.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  2. HUSAIN F, Pardo G, Rabadi M
    Headache and Its Management in Patients With Multiple Sclerosis.
    Curr Treat Options Neurol. 2018;20:10.
    PubMed     Text format     Abstract available


    Diabet Med

  3. WYATT RC, Brigatti C, Liberati D, Grace SL, et al
    The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.
    Diabet Med. 2018 Mar 25. doi: 10.1111/dme.13628.
    PubMed     Text format     Abstract available


    J Autoimmun

  4. LEWIS MJ, McAndrew MB, Wheeler C, Workman N, et al
    Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
    J Autoimmun. 2018 Mar 22. pii: S0896-8411(18)30023.
    PubMed     Text format     Abstract available


    J Immunol

  5. SUAREZ-FUEYO A, Bradley SJ, Katsuyama T, Solomon S, et al
    Downregulation of CD3zeta in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.
    J Immunol. 2018 Mar 30. pii: jimmunol.1700588. doi: 10.4049/jimmunol.1700588.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  6. ZAGORITI Z, Lagoumintzis G, Perroni G, Papathanasiou G, et al
    Evidence for association of STAT4 and IL12RB2 variants with Myasthenia gravis susceptibility: What is the effect on gene expression in thymus?
    J Neuroimmunol. 2018 Mar 17. pii: S0165-5728(17)30559.
    PubMed     Text format     Abstract available


    J Neurol

  7. COGHE G, Corona F, Marongiu E, Fenu G, et al
    Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial.
    J Neurol. 2018 Mar 24. pii: 10.1007/s00415-018-8836.
    PubMed     Text format     Abstract available


    J Pediatr

  8. PACHMAN LM, Khojah AM
    Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.
    J Pediatr. 2018;195:16-27.
    PubMed     Text format    


    Kidney Int

  9. VAN DE LOGT AE, Dahan K, Rousseau A, van der Molen R, et al
    Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
    Kidney Int. 2018;93:1016-1017.
    PubMed     Text format    

  10. ELLER K, Rosenkranz AR
    Atypical chemokine receptors-"chemokine PACMANs" as new therapeutic targets in glomerulonephritis.
    Kidney Int. 2018;93:774-775.
    PubMed     Text format     Abstract available


  11. Fu J, Wang Z, Lee K, et al. Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis. Kidney Int. 2018;93:416-429.
    Kidney Int. 2018;93:1018.
    PubMed     Text format    


    Lancet

  12. KAPPOS L, Bar-Or A, Cree BAC, Fox RJ, et al
    Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30475.
    PubMed     Text format     Abstract available

  13. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol

  14. WEISMAN A, Bai JW, Cardinez M, Kramer CK, et al
    Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.
    Lancet Diabetes Endocrinol. 2017 May 19. pii: S2213-8587(17)30167.
    PubMed     Text format     Abstract available

  15. MENTING J, Tack CJ, van Bon AC, Jansen HJ, et al
    Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial.
    Lancet Diabetes Endocrinol. 2017 Apr 24. pii: S2213-8587(17)30098.
    PubMed     Text format     Abstract available


    Mult Scler

  16. LEIBOVITCH EC, Lin CM, Billioux BJ, Graves J, et al
    Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls.
    Mult Scler. 2018 Mar 1:1352458518765654. doi: 10.1177/1352458518765654.
    PubMed     Text format     Abstract available

  17. TOLEDANO M, Weinshenker BG, Kaufmann TJ, Parisi JE, et al
    Demographics and clinical characteristics of episodic hypothermia in multiple sclerosis.
    Mult Scler. 2018 Mar 1:1352458518767045. doi: 10.1177/1352458518767045.
    PubMed     Text format     Abstract available

  18. VAN GEEST Q, Boeschoten RE, Keijzer MJ, Steenwijk MD, et al
    Fronto-limbic disconnection in patients with multiple sclerosis and depression.
    Mult Scler. 2018 Mar 1:1352458518767051. doi: 10.1177/1352458518767051.
    PubMed     Text format     Abstract available

  19. LANZILLO R, Moccia M, Criscuolo C, Cennamo G, et al
    Optical coherence tomography angiography detects retinal vascular alterations in different phases of multiple sclerosis.
    Mult Scler. 2018 Mar 1:1352458518768060. doi: 10.1177/1352458518768060.
    PubMed     Text format    


    Nat Rev Neurol

  20. GERALDES R, Ciccarelli O, Barkhof F, De Stefano N, et al
    The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
    Nat Rev Neurol. 2018;14:213.
    PubMed     Text format     Abstract available


    Neurology

  21. FERRARO D, Camera V, Vitetta F, Zennaro M, et al
    Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis.
    Neurology. 2018 Mar 30. pii: WNL.0000000000005417.
    PubMed     Text format    

  22. SAARELA M, Senthil K, Jones J, Tienari PJ, et al
    Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.
    Neurology. 2018 Mar 30. pii: WNL.0000000000005420.
    PubMed     Text format    


    Thyroid

  23. HAN YE, Hwang S, Kim JH, Byun JW, et al
    Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Thyroid. 2018 Mar 28. doi: 10.1089/thy.2017.0338.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: